“…In studies in which cytological-histological correlation has been available in BSRTC category III lesions, the risk of malignancy has been seen to fluctuate widely, from 19% to 77% (Dincer et al, 2013;Choi et al, 2014;Cuhaci et al, 2014;Ho et al, 2014;Hyeon et al, 2014;Rosario, 2014;Yoon et al, 2014;Deniwar et al, 2015;Kapila et al, 2015;Yoo et al, 2015). Also, there was a significant increase in the malignancy rate from sub-category FLUS to sub-category AUS in some (Choi et al, 2014), but not all (Cuhaci et al, 2014), investigations. By contrast, in BSRTC category IV, the risk of malignancy (27%-34%) reported in the most recent literature Nikiforov et al, 2014;Deniwar et al, 2015;Kapila et al, 2015) seems to be closer to that previously observed (Cibas and Ali, 2009).…”